A Genetically Engineered Macrophage-Derived Vesicular Nanodecoy Targeting the CD47/SIRPα Axis for Reinforced Tumor Radioimmunotherapy
ACS Nano · 2026-06-09 · 20 (22) · 16470-16487
DOI: 10.1021/acsnano.6c06363 ↗At a glance
Journal article in ACS Nano, published online on 2026-05-28. Written by Jinqiao Zhang and 8 co-authors. Institution: School of Life and Health Sciences, Hunan University of Science and Technology, Xiangtan 411201, P. R. China. Major MEDLINE topics: CD47 Antigen, Radioimmunotherapy, Macrophages, Receptors, Immunologic. 54 references. Funded by: Shandong First Medical University, Natural Science Foundation of Jiangsu Province, Taishan Scholar Project of Shandong Province.
Abstract (original language)
Není k dispozici žádný abstrakt.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Life and Health Sciences, Hunan University of Science and Technology, Xiangtan 411201, P. R. China.
- Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medicine Sciences, Jinan, Shandong 250117, P. R. China.
- State Key Laboratory of Flexible Electronics (LoFE) & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, Nanjing, Jiangsu 210000, P. R. China.
ORCID profiles: Ziliang Dong
Funding
- Shandong First Medical University
- Natural Science Foundation of Jiangsu Province
- Taishan Scholar Project of Shandong Province
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China (NSFC)
Cite
APA
Zhang, J., Tong, T., Cai, C., Cai, X., Sun, B., Wen, K., Qu, X., Fan, Q., & Dong, Z. (2026). A Genetically Engineered Macrophage-Derived Vesicular Nanodecoy Targeting the CD47/SIRPα Axis for Reinforced Tumor Radioimmunotherapy. ACS Nano, 20(22), 16470-16487. https://doi.org/10.1021/acsnano.6c06363
Vancouver
Zhang J, Tong T, Cai C, Cai X, Sun B, Wen K, et al. A Genetically Engineered Macrophage-Derived Vesicular Nanodecoy Targeting the CD47/SIRPα Axis for Reinforced Tumor Radioimmunotherapy. ACS Nano. 2026;20(22):16470-16487. doi:10.1021/acsnano.6c06363
BibTeX
@article{Zhang2026,
author = {Zhang, Jinqiao and Tong, Ting and Cai, Chang and Cai, Xianzhou and Sun, Bicheng and Wen, Kexin and Qu, Xinran and Fan, Qin and Dong, Ziliang},
title = {A Genetically Engineered Macrophage-Derived Vesicular Nanodecoy Targeting the CD47/SIRPα Axis for Reinforced Tumor Radioimmunotherapy},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {22},
pages = {16470--16487},
doi = {10.1021/acsnano.6c06363}
}
EUVIMED